![Tanya Lewis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tanya Lewis
Director/Board Member at
DIAMEDICA THERAPEUTICS INC.
Net worth: - $ as of 2026-05-30
Profile
Tanya N.
Lewis is currently an Independent Director at DiaMedica Therapeutics, Inc. since 2023 and a Director at Sernova Biotherapeutics, Inc. Former roles include Chief Development Operations Officer at Replimune Group, Inc. from 2021 to 2024; Chief Regulatory & Quality Officer, Executive VP at Karyopharm Therapeutics, Inc. from 2019 to 2021; Vice President-Regulatory & Quality Affairs at Syros Pharmaceuticals, Inc. from 2017 to 2018; VP-Regulatory Affairs & Quality Assurance at Idera Pharmaceuticals, Inc. from 2015 to 2016; VP-Regulatory Affairs & Quality Assurance at Tesaro, Inc. from 2011 to 2015; Senior Director-Regulatory Affairs at Millennium Pharmaceuticals, Inc. in 2008; and VP-Regulatory Affairs & Quality Assurance at both Vion Pharmaceuticals, Inc. and Seaside Therapeutics LLC.
Education includes graduate studies at Massachusetts College of Pharmacy & Health Science and undergraduate studies at Northeastern University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-21 | 0 ( -.--% ) | - $ | 2026-05-30 | |
| 2026-05-31 | 0 ( -.--% ) | - $ | 2026-05-30 |
Tanya Lewis active positions
| Companies | Position | Start |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Director/Board Member | 2023-02-28 |
| SERNOVA BIOTHERAPEUTICS INC | Director/Board Member | - |
Former positions of Tanya Lewis
| Companies | Position | End |
|---|---|---|
| REPLIMUNE GROUP, INC. | Director/Board Member | 2021-04-30 |
| KARYOPHARM THERAPEUTICS INC. | General Counsel | 2021-04-30 |
| SYROS PHARMACEUTICALS, INC. | General Counsel | 2018-06-30 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | General Counsel | 2016-11-30 |
| TESARO INC | General Counsel | 2015-05-31 |
Training of Tanya Lewis
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
54
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Vion Pharmaceuticals, Inc.
 Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small molecule anticancer compounds | Health Technology |
Sernova Biotherapeutics, Inc.
 Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
Massachusetts College of Pharmacy & Health Science
 Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seaside Therapeutics LLC
 Seaside Therapeutics LLC Medical DistributorsDistribution Services Develops drug treatments to correct or improve the course of fragile x syndrome | Distribution Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Syros Pharmaceuticals, Inc.
 Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
- Stock Market
- Insiders
- Tanya Lewis
